Drugs - Real World Outcomes targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related 'big data'. Drugs - Real World Outcomes has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses.

Drugs - Real World Outcomes offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review (single-blind) is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Upon acceptance for publication, manuscripts submitted to the journal will be subject to an article processing charge (APC) of US$2,200 or €2,000. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of the APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.

Journal information

Editor-in-Chief
  • Dene Peters
Associate Editor
  • Caroline Herdson
Publishing model
Open Access. Learn about OA at Springer

Journal metrics

41 days
Submission to first decision
122 days
Submission to acceptance
58,260 (2019)
Downloads

Latest articles

About this journal

Electronic ISSN
2198-9788
Abstracted and indexed in
  1. CNKI
  2. DOAJ
  3. Dimensions
  4. EBSCO Discovery Service
  5. EMBASE
  6. EMCare
  7. Gale
  8. Google Scholar
  9. Institute of Scientific and Technical Information of China
  10. Naver
  11. OCLC WorldCat Discovery Service
  12. ProQuest ABI/INFORM
  13. ProQuest Business Premium Collection
  14. ProQuest Central
  15. ProQuest-ExLibris Primo
  16. ProQuest-ExLibris Summon
  17. PubMedCentral
  18. SCImago
  19. SCOPUS
  20. Semantic Scholar
  21. UGC-CARE List (India)
Copyright information